Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05242510
Other study ID # STUDY00006849
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2024
Est. completion date July 1, 2025

Study information

Verified date February 2024
Source University of Rochester
Contact Matthew D Gearinger, MD
Phone 585 273-3937
Email matthew_gearinger@urmc.rochester.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study intends to determine the number and percent of subjects initially diagnosed with divergence excess exotropia which would be reclassified as simulated divergence excess exotropia if tested after 24 hours of monocular occlusion (patching) or after prism adaptation for the distance angle.


Recruitment information / eligibility

Status Recruiting
Enrollment 75
Est. completion date July 1, 2025
Est. primary completion date July 1, 2025
Accepts healthy volunteers No
Gender All
Age group N/A to 17 Years
Eligibility Inclusion Criteria: - Diagnosed with divergence excess exotropia according to standard criteria (see Study Procedures for specifics) - No prior strabismus surgery - Able to cooperate with testing (by examiner determination) - Neurologically normal except for strabismus (ADHD and autism spectrum are not exclusion criteria as long as the subject can cooperate for necessary testing) - Not amblyopic at the time of enrollment (best-corrected visual acuity in both eyes of 20/40 or better) - Under 18 years of age. There is no lower age limit as long as the subject can cooperate for the required testing. - No diagnosis of dissociated vertical deviation Exclusion Criteria: - No diagnosis of divergence excess exotropia according to standard criteria (see Study Procedures for specifics) - Prior strabismus surgery - Unable to cooperate with testing (by examiner determination) - Diagnosed with a neurological disorder (ADHD and autism spectrum are not exclusion criteria as long as the subject can cooperate for necessary testing) - Best-corrected visual acuity in either eye worse than 20/40 - 18 years of age or older - Diagnosed with dissociated vertical deviation

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Patching
The subject will occlude the non-dominant eye for 24 hours.
Prism Adaptation
The subject will undergo prism adaptation targeting the pre-occlusion distance angle for 1-2 weeks. • Fresnel prism(s) will be applied to the patient's spectacles equaling the distance angle between the two eyes. At the examiner's discretion depending on the size of the deviation, the prism(s) can be placed solely over the non-dominant eye, or split between the 2 eyes in some combination which results in equalization of the distance exotropia. If the distance angle calls for an amount of prism that cannot be exactly replicated with Fresnel prisms (e.g., 32 PD), the amount of prism used will be determined by rounding down to the nearest practical amount at examiner discretion.

Locations

Country Name City State
Canada Queen's University Kingston Ontario
India LV Prasad Eye Institute Hyderabad
Israel Shamir Medical Center Rishon LeZion Central
Italy University of Milan Milan
United States Harvard University Boston Massachusetts
United States Ross Eye Institute Buffalo New York
United States University of California Los Angeles Los Angeles California
United States University of Pittsburgh Pittsburgh Pennsylvania
United States University of Rochester Medical Center Rochester New York

Sponsors (1)

Lead Sponsor Collaborator
University of Rochester

Countries where clinical trial is conducted

United States,  Canada,  India,  Israel,  Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent of participants reclassified as divergence excess exotropia Percentage of patients with distance and near exotropia measurements within 2.5 prism diopters on alternate prism and cover testing after 24 hours of patching or 7-14 days of fresnel prism use. 2 weeks
Primary Percent of participants reclassified as simulated divergence excess exotropia Percentage of patients with distance and near exotropia measurements differing by more than 2.5 prism diopters on alternate prism and cover testing after 24 hours of patching or 7-14 days of fresnel prism use. 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT01460355 - Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone Phase 4
Not yet recruiting NCT06084442 - Evaluation of The Techniques in Correcting Large-Angle Exotropia N/A
Completed NCT02570555 - Strabismus Surgery and Driving Ability
Not yet recruiting NCT05089422 - Study of Clinical Types and Surgical Out Come of Pediatric Exotropia N/A
Not yet recruiting NCT06312865 - Intermittent Exotropia in Egyptian Population
Recruiting NCT05379855 - A-eyedrops on Ocular Alignment and Binocular Vision N/A
Completed NCT01032603 - Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia N/A
Completed NCT05643456 - Surgery for Large Angle Exotropia Two Muscles Versus Three Muscles N/A
Completed NCT01032330 - Observation Versus Occlusion Therapy for Intermittent Exotropia N/A
Not yet recruiting NCT03768362 - Comparison of Medial Rectus Resection and Plication in Exotropic Patients Phase 2/Phase 3
Recruiting NCT05615519 - Validation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus
Completed NCT03119311 - A Novel Diagnostic Method for Exotropia Using Video-oculography N/A
Recruiting NCT01616108 - Bupivacaine Injection of Eye Muscles to Treat Strabismus Phase 2/Phase 3